Assessment of Congenital Cytomegalovirus Prevalence among Newborns in Minnesota during the COVID-19 Pandemic

Mark R. Schleiss; Sondra Rosendahl; Mark McCann; Sheila C. Dollard; Tatiana M. Lanzieri

doi:10.1001/jamanetworkopen.2022.30020

Assessment of Congenital Cytomegalovirus Prevalence among Newborns in Minnesota during the COVID-19 Pandemic

Mark R. Schleiss, Sondra Rosendahl, Mark McCann, Sheila C. Dollard, Tatiana M. Lanzieri

Pediatrics - Infectious Disease

Research output: Contribution to journal › Letter › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	E2230020
Journal	JAMA Network Open
Volume	5
Issue number	9
DOIs	https://doi.org/10.1001/jamanetworkopen.2022.30020
State	Published - Sep 2 2022

Bibliographical note

Funding Information:
Funding/Support: This work was supported by the CDC, the National Vaccine Program Office, the Minnesota Department of Health Newborn Screening Program, and cooperative agreement number 6U19DD001218 from the DRDC.

Funding Information:
Conflict of Interest Disclosures: Dr Schleiss reported receiving grants from the US Centers for Disease Control and Prevention (CDC), the National Institutes of Health, and the University of South Carolina Disability Research and Dissemination Center (DRDC) during the conduct of the study; and receiving personal fees from Moderna, Sanofi, GlaxoSmithKline, and Merck outside the submitted work. Ms Rosendahl and Mr McCann reported receiving grants from the CDC during the conduct of the study. No other disclosures were reported.

PubMed: MeSH publication types

Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Access

10.1001/jamanetworkopen.2022.30020

OpenUrl availability

Full text

Cite this

@article{ad4bd03536ed41a4a1ab5926e1cff7bd,

title = "Assessment of Congenital Cytomegalovirus Prevalence among Newborns in Minnesota during the COVID-19 Pandemic",

author = "Schleiss, {Mark R.} and Sondra Rosendahl and Mark McCann and Dollard, {Sheila C.} and Lanzieri, {Tatiana M.}",

note = "Funding Information: Funding/Support: This work was supported by the CDC, the National Vaccine Program Office, the Minnesota Department of Health Newborn Screening Program, and cooperative agreement number 6U19DD001218 from the DRDC. Funding Information: Conflict of Interest Disclosures: Dr Schleiss reported receiving grants from the US Centers for Disease Control and Prevention (CDC), the National Institutes of Health, and the University of South Carolina Disability Research and Dissemination Center (DRDC) during the conduct of the study; and receiving personal fees from Moderna, Sanofi, GlaxoSmithKline, and Merck outside the submitted work. Ms Rosendahl and Mr McCann reported receiving grants from the CDC during the conduct of the study. No other disclosures were reported.",

year = "2022",

month = sep,

day = "2",

doi = "10.1001/jamanetworkopen.2022.30020",

language = "English (US)",

volume = "5",

pages = "E2230020",

journal = "JAMA Network Open",

issn = "2574-3805",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Assessment of Congenital Cytomegalovirus Prevalence among Newborns in Minnesota during the COVID-19 Pandemic

AU - Schleiss, Mark R.

AU - Rosendahl, Sondra

AU - McCann, Mark

AU - Dollard, Sheila C.

AU - Lanzieri, Tatiana M.

N1 - Funding Information: Funding/Support: This work was supported by the CDC, the National Vaccine Program Office, the Minnesota Department of Health Newborn Screening Program, and cooperative agreement number 6U19DD001218 from the DRDC. Funding Information: Conflict of Interest Disclosures: Dr Schleiss reported receiving grants from the US Centers for Disease Control and Prevention (CDC), the National Institutes of Health, and the University of South Carolina Disability Research and Dissemination Center (DRDC) during the conduct of the study; and receiving personal fees from Moderna, Sanofi, GlaxoSmithKline, and Merck outside the submitted work. Ms Rosendahl and Mr McCann reported receiving grants from the CDC during the conduct of the study. No other disclosures were reported.

PY - 2022/9/2

Y1 - 2022/9/2

UR - http://www.scopus.com/inward/record.url?scp=85137157864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137157864&partnerID=8YFLogxK

U2 - 10.1001/jamanetworkopen.2022.30020

DO - 10.1001/jamanetworkopen.2022.30020

M3 - Letter

C2 - 36053537

AN - SCOPUS:85137157864

SN - 2574-3805

VL - 5

SP - E2230020

JO - JAMA Network Open

JF - JAMA Network Open

IS - 9

ER -

Assessment of Congenital Cytomegalovirus Prevalence among Newborns in Minnesota during the COVID-19 Pandemic

Bibliographical note

PubMed: MeSH publication types

Access

OpenUrl availability

Other files and links

Cite this